Company Filing History:
Years Active: 2023
Title: Innovations of Ivan Ho Chan in Immunotherapy
Introduction
Ivan Ho Chan is a notable inventor based in Millbrae, California. He has made significant contributions to the field of immunotherapy, particularly in the production of antigen-specific CD8+ T cells. His work focuses on developing methods and compositions that enhance the therapeutic potential of these immune cells.
Latest Patents
Ivan Ho Chan holds a patent for "Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same." This patent provides methods and compositions related to isolated CD8+ T cells that express a disease antigen-specific T cell receptor. The patent outlines how these CD8+ T cells can be obtained from the blood of subjects with diseases that can be treated using IL-10 agents. Additionally, it discusses therapeutic methods for administering these isolated cells and genetically modified CD8+ T cells.
Career Highlights
Ivan Ho Chan is currently employed at Eli Lilly and Company, where he continues to advance his research in immunotherapy. His innovative approaches have the potential to significantly impact the treatment of various diseases.
Collaborations
Ivan has collaborated with notable colleagues, including John Brian Mumm and Scott McCauley. Their combined expertise contributes to the advancement of research in the field of immunotherapy.
Conclusion
Ivan Ho Chan's work exemplifies the innovative spirit in the field of immunotherapy. His contributions through patents and collaborations are paving the way for new therapeutic strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.